Terms: = Liver cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Diagnosis
516 results:
1. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced liver MRI.
Yoon JH; Kim YK; Kim JW; Chang W; Choi JI; Park BJ; Choi JY; Kim SS; Park HS; Lee ES; Yu JS; Park SJ; You MW; Lee CH; Lee JM
Radiology; 2024 Apr; 311(1):e233114. PubMed ID: 38563667
[TBL] [Abstract] [Full Text] [Related]
3. Case 322: Pyothorax-associated Lymphoma.
Hu JY; Lee KH; Yun G
Radiology; 2024 Feb; 310(2):e223090. PubMed ID: 38411510
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Proteomics Reveals Functional Targets for Early Diabetes Susceptibility in Young Adults.
Shah RV; Zhong J; Massier L; Tanriverdi K; Hwang SJ; Haessler J; Nayor M; Zhao S; Perry AS; Wilkins JT; Shadyab AH; Manson JE; Martin L; Levy D; Kooperberg C; Freedman JE; Rydén M; Murthy VL
Circ Genom Precis Med; 2024 Feb; 17(1):e004192. PubMed ID: 38323454
[TBL] [Abstract] [Full Text] [Related]
5. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
[TBL] [Abstract] [Full Text] [Related]
6. Image-guided percutaneous ablation of hepatic epithelioid hemangioendothelioma.
Hu EY; Bhagavatula SK; Shi A; Merriam P; Levesque VM; Shyn PB
Abdom Radiol (NY); 2024 Apr; 49(4):1241-1247. PubMed ID: 38240859
[TBL] [Abstract] [Full Text] [Related]
7. Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma diagnosis.
Goins SM; Jiang H; van der Pol CB; Salameh JP; Lam E; Adamo RG; McInnes MDF; Costa AF; Tang A; Alhasan AS; Allen BC; Reiner CS; Clarke C; Cerny M; Wang J; Choi SH; Fraum TJ; Ludwig DR; Song B; Joo I; Kang Z; Kierans AS; Kim SY; Kwon H; Ronot M; Podgórska J; Rosiak G; Song JS; Bashir MR
Radiology; 2023 Dec; 309(3):e231656. PubMed ID: 38112549
[TBL] [Abstract] [Full Text] [Related]
8. Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Bafaloukos D; Kouzis P; Gouveris P; Boukovinas I; Kalbakis K; Baka S; Kyriakakis G; Moschou D; Molfeta A; Demiri S; Mavroudis D; Spanoudi F; Dimitriadis I; Gogas H
Melanoma Res; 2024 Apr; 34(2):152-165. PubMed ID: 38092014
[TBL] [Abstract] [Full Text] [Related]
9. Community-Level Factors Associated with Hepatocellular Carcinoma Incidence and Mortality: An Observational Registry Study.
Mezzacappa C; Rossi R; Jaffe A; Taddei TH; Strazzabosco M
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):270-278. PubMed ID: 38059831
[TBL] [Abstract] [Full Text] [Related]
10. MR Fingerprinting for Contrast Agent-free and Quantitative Characterization of Focal liver Lesions.
Fujita S; Sano K; Cruz G; Velasco C; Kawasaki H; Fukumura Y; Yoneyama M; Suzuki A; Yamamoto K; Morita Y; Arai T; Fukunaga I; Uchida W; Kamagata K; Abe O; Kuwatsuru R; Saiura A; Ikejima K; Botnar R; Prieto C; Aoki S
Radiol Imaging Cancer; 2023 Nov; 5(6):e230036. PubMed ID: 37999629
[TBL] [Abstract] [Full Text] [Related]
11. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
[TBL] [Abstract] [Full Text] [Related]
12. Case 322.
Hu JY; Lee KH; Yun G
Radiology; 2023 Oct; 309(1):e223089. PubMed ID: 37906006
[TBL] [Abstract] [Full Text] [Related]
13. Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts.
Petővári G; Tóth G; Turiák L; L Kiss A; Pálóczi K; Sebestyén A; Pesti A; Kiss A; Baghy K; Dezső K; Füle T; Tátrai P; Kovalszky I; Reszegi A
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762298
[TBL] [Abstract] [Full Text] [Related]
14. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
[TBL] [Abstract] [Full Text] [Related]
15. Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case-control study.
Şenel E; Salmanoğlu M; Solmazgül E; İnal BB
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1811-1814. PubMed ID: 37622223
[TBL] [Abstract] [Full Text] [Related]
16. Metastatic pituitary tumors: an institutional case series.
Yearley AG; Chalif EJ; Gupta S; Chalif JI; Bernstock JD; Nawabi N; Arnaout O; Smith TR; Reardon DA; Laws ER
Pituitary; 2023 Oct; 26(5):561-572. PubMed ID: 37523025
[TBL] [Abstract] [Full Text] [Related]
17. Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods.
Han S; Kim SW; Park S; Yoon JH; Kang HJ; Yoo J; Joo I; Bae JS; Lee JM
Ultrasound Med Biol; 2023 Oct; 49(10):2256-2263. PubMed ID: 37495497
[TBL] [Abstract] [Full Text] [Related]
18. Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis.
Behari J; Gougol A; Wang R; Luu HN; Paragomi P; Yu YC; Molinari M; Chopra K; Malik SM; Geller D; Yuan JM
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37395730
[TBL] [Abstract] [Full Text] [Related]
19. Hyperbilirubinemia in hospitalized patients: Etiology and outcomes.
Kwon JY; Nietert PJ; Rockey DC
J Investig Med; 2023 Oct; 71(7):773-781. PubMed ID: 37386866
[TBL] [Abstract] [Full Text] [Related]
20. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
[TBL] [Abstract] [Full Text] [Related]
[Next]
